摘要
目的探讨心肌梗死(MI)后患者心脏胶原重塑与血清基质金属蛋白酶-1(MMP-1)及其抑制因子(TIMP-1)水平的变化。方法测定首次发病的MI住院患者(MI组)发病后1周、3个月、6个月的血清Ⅰ型前胶原羧基端肽(PⅠCP)和Ⅲ型前胶原(PCⅢ)、MMP-1、TIMP-1的水平,并计算PⅠCP/PCⅢ比值。以48例健康体检者作为正常对照组。结果与对照组比较,MI组PⅠCP水平在MI后3个月、6个月组明显高于对照组(P<0.05),血清PCⅢ水平在MI后各时间点均明显升高(P<0.05),MI后各时间点的PⅠCP/PCⅢ比值和血清MMP-1、TIMP-1水平均明显降低(P<0.05)。结论MI后心脏胶原合成代谢旺盛,MMP-1/TIMP-1参与MI后心脏胶原重塑的病理生理进程。
Objective To observe the changes of matrix rnetalloproteinase-1 (MMP-1), tissue inhibitor-1 (TIMP-1), and cardiac collagen remodeling in patients with acute myocardial infarction (AMI). Methods 65 patients with AMI and 48 normal controls (age-, sex-matched) were enrolled in this study. Blood samples were obtained from the normal controls and the patients with AMI on the 1st week, the 3 rd month and the 6th month after AML The serum levels of MMP-1, TIMP-1, the carboxy-terminal propeptide of type I procollagen (P I CP) and precollagen Ⅲ (PCⅢ) were measured by enzyme-linked immunosorbent assay (ELISA). Results Compared with the normal control, the serum level of P I CP on the 3 rd month and the 6th month, the level of PC Ⅲat all times, increased in AMI group. The ratio of P I CP/PCⅢ, the level of MMP-1 and TIMP-1 were significantly lower in AMI group than those in normal controls. Conclusion The results show that synthesis of myocardial collagen is upregulated after AMI, MMP-1/TIMP-1 may participate in cardiac collagen remodeling.
出处
《贵州医药》
CAS
2008年第11期970-972,共3页
Guizhou Medical Journal
基金
贵州省科学技术基金资助项目[黔基合计字(2003)3043]
贵州省高层次人才科研条件特助经费项目[黔人领函(2005)14]
关键词
基质金属蛋白酶
心肌梗死
胶原重塑
Matrix metalloproteinase Myocardial infarction Collagen remodling